Lineage Cell Therapeutics, Inc. - LCTX
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$170M
QoQ value delta ($000)
+$21.43M
(+14.42%)
Implied price effect (QoQ)
-1.17%
Shares
Total shares
101,832,314
QoQ shares delta
+13,874,533
(+15.77%)
Total shares held by funds (by quarter)
Market chart (LCTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 82,766 | 49,560,992 | 4.86% |
| VANGUARD GROUP INC | 16,105 | 9,644,276 | 0.0% |
| Defender Capital, LLC. | 11,405 | 6,829,099 | 3.7% |
| RAFFLES ASSOCIATES LP | 8,955 | 5,362,788 | 6.72% |
| COMERICA BANK | 7,682 | 4,600,000 | 0.03% |
| BlackRock, Inc. | 6,402 | 3,834,113 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 4,112 | 2,461,193 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 4,016 | 2,404,800 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 3,524 | 2,110,419 | 0.0% |
| MORGAN STANLEY | 3,337 | 1,998,663 | 0.0% |
| GOLDMAN SACHS GROUP INC | 2,402 | 1,438,746 | 0.0% |
| MARSHALL WACE, LLP | 2,274 | 1,362,061 | 0.0% |
| STATE STREET CORP | 1,697 | 1,016,211 | 0.0% |
| JANE STREET GROUP, LLC | 1,678 | 1,004,794 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,353 | 810,615 | 0.0% |
| RED CRANE WEALTH MANAGEMENT, LLC | 997 | 597,263 | 0.82% |
| CITADEL ADVISORS LLC | 891 | 533,752 | 0.0% |
| NORTHERN TRUST CORP | 800 | 479,273 | 0.0% |
| Informed Momentum Co LLC | 738 | 442,221 | 0.08% |
| BARCLAYS PLC | 582 | 348,510 | 0.0% |
| GSA CAPITAL PARTNERS LLP | 553 | 330,981 | 0.05% |
| OMERS ADMINISTRATION Corp | 472 | 283,200 | 0.0% |
| SEI INVESTMENTS CO | 449 | 269,311 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 443 | 265,585 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 369 | 221,000 | 0.01% |